View of Longitudinal impact of sodium-glucose co-transporter-2 versus dipeptidyl peptidase-4 inhibitors on weight and body mass index in type 2 diabetes: a 12-month comparative analysis

Return to Article Details Longitudinal impact of sodium-glucose co-transporter-2 versus dipeptidyl peptidase-4 inhibitors on weight and body mass index in type 2 diabetes: a 12-month comparative analysis Download Download PDF